Opioid Exposed | List of Frontiers open access articles

Brief Research Report

Published on 07 May 2024

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research

in Neonatology

Shahla M. Jilani
Jonathan M. Davis
David Goldstein
Matthew Grossman
Lauren M. Jansson
Mishka Terplan
Hendrée E. Jones

Frontiers in Pediatrics

doi 10.3389/fped.2024.1349102

2,125 views
2 citations

Original Research

Published on 15 Jun 2023

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome

in Epigenomics and Epigenetics

Uppala Radhakrishna
Swapan K. Nath
Lavanya V. Uppala
Avinash Veerappa
Ariadna Forray
Srinivas B. Muvvala
Raghu P. Metpally
Richard C. Crist
Wade H. Berrettini
Lori M. Mausi

Frontiers in Genetics

doi 10.3389/fgene.2023.1215472

5,532 views
4 citations

Original Research

Accepted on 27 Feb 2026

Maternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot Study

in Neonatology

Elizabeth Yen
Kiran Singh
Marissa Chow
Francesca Carasi-Schwartz
Mario Cordova
Tomoko Kaneko-Tarui
Emily Brew
Taysir Mahmoud
Pratik Reddy
Angie Mae Rodday

Frontiers in Pediatrics

Original Research

Published on 17 Apr 2025

Prenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome

in Pediatric Pain

Uppala Radhakrishna
Rupa Radhakrishnan
Lavanya V. Uppala
Tithi S. Trivedi
Jignesh Prajapati
Rakesh M. Rawal
Srinivas B. Muvvala
Ray O. Bahado-Singh
Senthilkumar Sadhasivam

Frontiers in Pain Research

doi 10.3389/fpain.2025.1497801

7,924 views
2 citations

Review

Published on 28 Oct 2021

An Integrated Mechanistic Model of Mindfulness-Oriented Recovery Enhancement for Opioid-Exposed Mother–Infant Dyads

in Human Developmental Psychology

Sarah E. Reese
Elisabeth Conradt
Michael R. Riquino
Eric L. Garland

Frontiers in Psychology

doi 10.3389/fpsyg.2021.688359

5,244 views

Original Research

Published on 09 Feb 2022

Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice

in Motivation and Reward

Bing Li
Junyu Jiang
Li Zhou
Xinrong Tao
Qixian Sun
Jiaxin Liu
Yang Liu
Gang Pang

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2021.797217

6,158 views
9 citations

Mini Review

Published on 21 Jan 2022

Aberrant Feeding and Growth in Neonates With Prenatal Opioid Exposure: Evidence of Neuromodulation and Behavioral Changes

in Neonatology

Elizabeth Yen
Jill L. Maron

Frontiers in Pediatrics

doi 10.3389/fped.2021.805763

5,290 views
16 citations

Review

Published on 13 Aug 2021

Adapting an Evidence-Based Home Visiting Intervention for Mothers With Opioid Dependence: Modified Attachment and Biobehavioral Catch-up

in Human Developmental Psychology

Madelyn H. Labella
Rina D. Eiden
Caroline K. P. Roben
Mary Dozier

Frontiers in Psychology

doi 10.3389/fpsyg.2021.675866

6,525 views
8 citations

Original Research

Published on 04 Jan 2024

Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons

in Human and Medical Genomics

Uppala Radhakrishna
Senthilkumar Sadhasivam
Rupa Radhakrishnan
Ariadna Forray
Srinivas B. Muvvala
Raghu P. Metpally
Saumya Patel
Rakesh M. Rawal
Sangeetha Vishweswaraiah
Ray O. Bahado-Singh

Frontiers in Genetics

doi 10.3389/fgene.2023.1292148

5,275 views
4 citations

Original Research

Published on 19 Aug 2024

Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome

in Neuropharmacology

Uppala Radhakrishna
Rupa Radhakrishnan
Lavanya V. Uppala
Srinivas B. Muvvala
Jignesh Prajapati
Rakesh M. Rawal
Ray O. Bahado-Singh
Senthilkumar Sadhasivam

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1442915

6,294 views
3 citations

Articles

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome

Maternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot Study

Prenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome

An Integrated Mechanistic Model of Mindfulness-Oriented Recovery Enhancement for Opioid-Exposed Mother–Infant Dyads

Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice

Aberrant Feeding and Growth in Neonates With Prenatal Opioid Exposure: Evidence of Neuromodulation and Behavioral Changes

Adapting an Evidence-Based Home Visiting Intervention for Mothers With Opioid Dependence: Modified Attachment and Biobehavioral Catch-up

Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons

Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome